Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 91.30 INR
Change Today -2.40 / -2.56%
Volume 512.4K
LYKA On Other Exchanges
Symbol
Exchange
Natl India
As of 7:06 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

lyka labs ltd (LYKA) Snapshot

Open
93.95
Previous Close
93.70
Day High
95.00
Day Low
90.20
52 Week High
07/31/15 - 95.00
52 Week Low
09/10/14 - 13.15
Market Cap
2.0B
Average Volume 10 Days
1.0M
EPS TTM
-14.79
Shares Outstanding
21.6M
EX-Date
08/12/96
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for LYKA LABS LTD (LYKA)

Related News

No related news articles were found.

lyka labs ltd (LYKA) Related Businessweek News

No Related Businessweek News Found

lyka labs ltd (LYKA) Details

Lyka Labs Limited provides pharmaceutical products and pharma related services in India. It undertakes contract manufacturing activities. The company manufactures and sells lyophilized products; and finished formulations, including new caphalesporin combination injections, tablets, ointments, and syrups. It also markets various products to hospitals and institutions, such as anti-infectives comprising systemic antimalarial, antifungal, and antibacterials for serious infections; and anesthetics, anti-ulcerants, and steroids in parenteral dosage forms. In addition, the company offers animal healthcare products consisting of feed supplements, oral calcium/tonics, specialties, antibiotics, and anthelmintics; LYKASCOPE, a diagnostic tool; and mineral mixture. Further, it manufactures generic drugs in the form of tablets, capsules, ointments, and syrups dry powder and liquid. The company also exports its products to Russia, Vietnam, Sudan, Bangladesh, Chile, Cambodia, Zaire, Kenya, Ghana, Sri Lanka, Myanmar, and Panama. Lyka Labs Limited was incorporated in 1976 and is headquartered in Mumbai, India.

Founded in 1976

lyka labs ltd (LYKA) Top Compensated Officers

Chairman, Managing Director, Chairman of Shar...
Total Annual Compensation: 3.8M
Compensation as of Fiscal Year 2014.

lyka labs ltd (LYKA) Key Developments

Lyka Labs Ltd Approves Appointment of Yatin N Shah as Indepdent Director

Lyka Labs Ltd announced that the Board of Directors of the company at its meeting held on April 24, 2015, appointed Mr. Yatin N Shah, Practicing Company Secretary as an Indepdent Director subject to approval by the Shareholders in the General Meeting.

Lyka Labs Ltd. Announces Resignation of Vinodkant A. Sanghani as Independent Director

Lyka Labs Ltd. announced that Vinodkant A. Sanghani - Independent Director has tendered his resignation from the Directorship of the company due to his physical illness vide his letter dated April 07, 2015.

Lyka Labs Ltd. Reports Standalone Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2015

Lyka Labs Ltd. reported standalone unaudited earnings results for the third quarter and nine months ended March 31, 2015. For the quarter, the company reported net sales/income from operations of INR 179.404 million against INR 217.426 million a year ago. Profit from operations before other income, finance cost and exceptional items was INR 31.519 million against loss from operations before other income, finance cost and exceptional items of INR 46.205 million a year ago. Loss from ordinary activities before tax was INR 3.536 million against INR 183.660 million a year ago. Net loss from ordinary activities after tax was INR 3.536 million or INR 0.18 per basic and diluted share before extraordinary items and INR 0.81 per basic and diluted share after extraordinary items against INR 183.660 million or INR 8.51 per basic and diluted share before extraordinary items and INR 7.49 earnings per basic and diluted share after extraordinary items a year ago. For the nine, the company reported net sales/income from operations of INR 580.355 million against INR 661.700 million a year ago. Profit from operations before other income, finance cost and exceptional items was INR 106.011 million against loss from operations before other income, finance cost and exceptional items of INR 91.423 million a year ago. Profit from ordinary activities before tax was INR 11.147 million against loss of INR 342.416 million a year ago. Net profit from ordinary activities after tax was INR 11.147 million or INR 0.48 per basic and diluted share before extraordinary items and INR 15.87 per basic and diluted share after extraordinary items against net loss of INR 342.216 million or INR 0.48 per basic and diluted share before extraordinary items and INR 0.13 earnings per basic and diluted share after extraordinary items a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LYKA:IN 91.30 INR -2.40

LYKA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LYKA.
View Industry Companies
 

Industry Analysis

LYKA

Industry Average

Valuation LYKA Industry Range
No financial data is available for LYKA.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LYKA LABS LTD, please visit www.lykalabs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.